907 related articles for article (PubMed ID: 16729877)
21. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
22. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
[TBL] [Abstract][Full Text] [Related]
23. Discovery and validation of breast cancer subtypes.
Kapp AV; Jeffrey SS; Langerød A; Børresen-Dale AL; Han W; Noh DY; Bukholm IR; Nicolau M; Brown PO; Tibshirani R
BMC Genomics; 2006 Sep; 7():231. PubMed ID: 16965636
[TBL] [Abstract][Full Text] [Related]
24. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
[TBL] [Abstract][Full Text] [Related]
25. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
Klemm F; Bleckmann A; Siam L; Chuang HN; Rietkötter E; Behme D; Schulz M; Schaffrinski M; Schindler S; Trümper L; Kramer F; Beissbarth T; Stadelmann C; Binder C; Pukrop T
Carcinogenesis; 2011 Mar; 32(3):434-42. PubMed ID: 21173432
[TBL] [Abstract][Full Text] [Related]
26. Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.
Gonçalves A; Charafe-Jauffret E; Bertucci F; Audebert S; Toiron Y; Esterni B; Monville F; Tarpin C; Jacquemier J; Houvenaeghel G; Chabannon C; Extra JM; Viens P; Borg JP; Birnbaum D
Mol Cell Proteomics; 2008 Aug; 7(8):1420-33. PubMed ID: 18426791
[TBL] [Abstract][Full Text] [Related]
27. Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.
Grigoriadis A; Mackay A; Reis-Filho JS; Steele D; Iseli C; Stevenson BJ; Jongeneel CV; Valgeirsson H; Fenwick K; Iravani M; Leao M; Simpson AJ; Strausberg RL; Jat PS; Ashworth A; Neville AM; O'Hare MJ
Breast Cancer Res; 2006; 8(5):R56. PubMed ID: 17014703
[TBL] [Abstract][Full Text] [Related]
28. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
[TBL] [Abstract][Full Text] [Related]
29. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
30. Challenges in projecting clustering results across gene expression-profiling datasets.
Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
[TBL] [Abstract][Full Text] [Related]
31. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
[TBL] [Abstract][Full Text] [Related]
32. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.
Bergamaschi A; Tagliabue E; Sørlie T; Naume B; Triulzi T; Orlandi R; Russnes HG; Nesland JM; Tammi R; Auvinen P; Kosma VM; Ménard S; Børresen-Dale AL
J Pathol; 2008 Feb; 214(3):357-67. PubMed ID: 18044827
[TBL] [Abstract][Full Text] [Related]
33. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.
Holm K; Hegardt C; Staaf J; Vallon-Christersson J; Jönsson G; Olsson H; Borg A; Ringnér M
Breast Cancer Res; 2010; 12(3):R36. PubMed ID: 20565864
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
Bertucci F; Finetti P; Cervera N; Charafe-Jauffret E; Mamessier E; Adélaïde J; Debono S; Houvenaeghel G; Maraninchi D; Viens P; Charpin C; Jacquemier J; Birnbaum D
Cancer Res; 2006 May; 66(9):4636-44. PubMed ID: 16651414
[TBL] [Abstract][Full Text] [Related]
35. Long versus short oligonucleotide microarrays for the study of gene expression in nonhuman primates.
Walker SJ; Wang Y; Grant KA; Chan F; Hellmann GM
J Neurosci Methods; 2006 Apr; 152(1-2):179-89. PubMed ID: 16253343
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
37. Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.
Karn T; Pusztai L; Ruckhäberle E; Liedtke C; Müller V; Schmidt M; Metzler D; Wang J; Coombes KR; Gätje R; Hanker L; Solbach C; Ahr A; Holtrich U; Rody A; Kaufmann M
Eur J Cancer; 2012 Jan; 48(1):12-23. PubMed ID: 21741824
[TBL] [Abstract][Full Text] [Related]
38. Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements.
Carter SL; Eklund AC; Mecham BH; Kohane IS; Szallasi Z
BMC Bioinformatics; 2005 Apr; 6():107. PubMed ID: 15850491
[TBL] [Abstract][Full Text] [Related]
39. Characterization of molecular subtypes of Korean breast cancer: an ethnically and clinically distinct population.
Han W; Nicolau M; Noh DY; Jeffrey SS
Int J Oncol; 2010 Jul; 37(1):51-9. PubMed ID: 20514396
[TBL] [Abstract][Full Text] [Related]
40. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.
Dadhania V; Zhang M; Zhang L; Bondaruk J; Majewski T; Siefker-Radtke A; Guo CC; Dinney C; Cogdell DE; Zhang S; Lee S; Lee JG; Weinstein JN; Baggerly K; McConkey D; Czerniak B
EBioMedicine; 2016 Oct; 12():105-117. PubMed ID: 27612592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
